<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04470466</url>
  </required_header>
  <id_info>
    <org_study_id>las49</org_study_id>
    <nct_id>NCT04470466</nct_id>
  </id_info>
  <brief_title>Short Pulse and Q-switched ND-YAG Laser With Topical Carbon Versus Fractional CO2 Laser for Enlarged Facial Pores</brief_title>
  <official_title>Short Pulse and Q-switched ND-YAG Laser With Topical Carbon Versus Fractional CO2 Laser in Treatment of Enlarged Facial Pores: A Split-face Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Facial pores are visible topographic features of the skin that reflect openings of&#xD;
      pilosebaceous follicles, that may be enlarged causing distress to some individuals. Many&#xD;
      patients desire treatment for this condition, which can be an early sign of skin aging.&#xD;
      Therapeutic modalities include intense pulsed light, radiofrequency, dermabrasion, oral and&#xD;
      topical retinoids, as well as chemical peeling. Lasers, as fractional CO2, short pulse and&#xD;
      Q-switched Nd-YAG, can potentially be used in treatment of wide pores.&#xD;
&#xD;
      This study aims at the assessment and comparison of therapy with short pulsed and Q-switched&#xD;
      Nd-YAG laser plus topical carbon with fractional CO2 laser in the management of wide facial&#xD;
      pores.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      topical carbon cream will be applied to one side of the face in patients with wide facial&#xD;
      pores, followed by 2 passes of short pulse 1064 ND:YAG laser, then one pass of Q-switched&#xD;
      ND-YAG laser.&#xD;
&#xD;
      fractional CO2 laser will be performed to the other half of the face. the patients will&#xD;
      receive 2 treatment sessions&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 19, 2020</start_date>
  <completion_date type="Actual">October 12, 2020</completion_date>
  <primary_completion_date type="Actual">October 12, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the percentage of decrease in size of enlarged facial pores assessed clinically and by dermoscopy</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Skin Lesion</condition>
  <arm_group>
    <arm_group_label>short pulse and Q-switched ND-YAG laser with topical carbon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractional CO2 Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>short pulse and Q-switched ND-YAG laser with topical carbon</intervention_name>
    <description>application of topical carbon cream, followed by two passes of short pulse 1064 ND-YAG, then one pass of Q-switched 1064 ND-YAG on one side of the face</description>
    <arm_group_label>short pulse and Q-switched ND-YAG laser with topical carbon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fractional CO2 laser</intervention_name>
    <description>single pass of fractional CO2 laser on the other side of the face</description>
    <arm_group_label>Fractional CO2 Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants who are more than 18 years old with the large facial pores and are aware&#xD;
             of their problem and seeking treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Previous laser therapy, chemical peeling, microdermabrasion or cosmetic procedure&#xD;
             for the face.&#xD;
&#xD;
               -  Patients with any contraindication to laser therapy such as photosensitive&#xD;
                  diseases, skin malignancies, patients on oral retinoids.&#xD;
&#xD;
               -  Keloid-forming tendency.&#xD;
&#xD;
               -  Local or systemic treatment for skin pores in the previous 3 months&#xD;
&#xD;
               -  Connective tissue disease or the use of immunosuppressive medications.&#xD;
&#xD;
               -  Pregnancy.&#xD;
&#xD;
               -  Present or past history of herpes labialis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr Alainy</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>July 4, 2020</study_first_submitted>
  <study_first_submitted_qc>July 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2020</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Dina Saadi</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

